Lead Product(s) : 2-Hydroxyoleic Acid
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Trial to Evaluate Safety, Tolerability and Efficacy of NFX88 in SCI
Details : NFX88 is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Neuralgia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 01, 2019
Lead Product(s) : 2-Hydroxyoleic Acid
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable